COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 207.2 | 1 | 0140-0449 | 914.46 | 449.53 | 412 | 80.18 | 0.805 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 282.1 | 1 | 0141-0450 | 293.65 | 450.79 | 391 | 75.50 | 0.862 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 297.9 | 1 | 0142-0453 | 562.54 | 453.36 | 701 | 99.64 | 0.887 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 214.3 | 1 | 0143-0449 | 715.45 | 448.99 | 390 | 76.08 | 0.847 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 576.7 | 1 | 0144-0454 | 142.77 | 454.03 | 401 | 77.50 | 0.839 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 216.6 | 1 | 0145-0455 | 946.44 | 455.06 | 407 | 78.08 | 0.839 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 490.0 | 1 | 0146-0465 | 186.09 | 465.22 | 378 | 73.50 | 0.879 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 214.5 | 1 | 0147-0473 | 48.87 | 472.73 | 757 | 108.81 | 0.803 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 218.6 | 1 | 0148-0468 | 763.11 | 467.65 | 373 | 73.26 | 0.873 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 333.5 | 1 | 0149-0479 | 695.70 | 479.85 | 998 | 122.81 | 0.832 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 228.9 | 1 | 0150-0476 | 640.27 | 476.07 | 384 | 73.84 | 0.885 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 204.3 | 1 | 0151-0480 | 336.26 | 480.21 | 402 | 76.77 | 0.857 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 250.9 | 1 | 0152-0483 | 393.22 | 482.93 | 564 | 89.98 | 0.875 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 223.1 | 1 | 0153-0480 | 849.69 | 480.79 | 391 | 74.77 | 0.879 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 272.6 | 1 | 0154-0484 | 443.37 | 484.11 | 426 | 77.84 | 0.884 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 268.5 | 1 | 0155-0484 | 213.28 | 483.94 | 379 | 71.60 | 0.929 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 233.6 | 1 | 0156-0487 | 770.70 | 487.97 | 410 | 79.15 | 0.822 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 254.4 | 1 | 0157-0490 | 533.71 | 490.14 | 403 | 78.08 | 0.831 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 264.7 | 1 | 0158-0489 | 573.51 | 488.99 | 384 | 74.67 | 0.865 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 221.7 | 1 | 0159-0488 | 313.19 | 488.37 | 428 | 79.60 | 0.849 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 187.9 | 1 | 0160-0497 | 87.71 | 497.66 | 366 | 71.84 | 0.891 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 247.5 | 1 | 0161-0499 | 866.23 | 499.79 | 410 | 78.08 | 0.845 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 207.5 | 1 | 0162-0499 | 922.02 | 498.94 | 359 | 69.60 | 0.931 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 162.0 | 1 | 0163-0506 | 45.32 | 507.06 | 382 | 78.91 | 0.771 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 248.1 | 1 | 0164-0508 | 817.58 | 507.77 | 374 | 72.43 | 0.896 |